DNA methylation signature to identify treatment response in triple negative breast cancer.

被引：0
|
作者：
Pineda, Begona
Diaz-Lagares, Angel
Alejandro Perez-Fidalgo, Jose
Alonso, Elisa
Sandoval, Juan
Gonzalez, Ines
Crujeiras, Ana-Belen
Burgues, Octavio
Esteller, Manel
Lluch, Ana
Eroles, Pilar
机构：
[1] INCLIVA, Valencia, Spain
[2] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain
[3] Univ Valencia, Hosp Clin, Valencia, Spain
[4] Hosp Clin Valencia, Phatol Deparment, Valencia, Spain
[5] Hosp Clin Valencia, Valencia, Spain
[6] Inst Invest Biomed Bellvitge, Barcelona, Spain
[7] Inst Hlth Res INCLIVA, Valencia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.1079
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1079
引用
收藏
页数：1
相关论文
共 50 条
  • [1] DNA methylation-based biological age and time to relapse in triple negative breast cancer.
    Nannini, Drew Robert
    Nandu, Nitish
    Hildebrandt, Gerhard
    Cortese, Rene
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] DNA repair signature is associated with anthracycline response in triple negative breast cancer patients
    A. A. Rodriguez
    A. Makris
    M. F. Wu
    M. Rimawi
    A. Froehlich
    B. Dave
    S. G. Hilsenbeck
    G. C. Chamness
    M. T. Lewis
    L. E. Dobrolecki
    D. Jain
    S. Sahoo
    C. K. Osborne
    J. C. Chang
    [J]. Breast Cancer Research and Treatment, 2010, 123 : 189 - 196
  • [3] DNA repair signature is associated with anthracycline response in triple negative breast cancer patients
    Rodriguez, A. A.
    Makris, A.
    Wu, M. F.
    Rimawi, M.
    Froehlich, A.
    Dave, B.
    Hilsenbeck, S. G.
    Chamness, G. C.
    Lewis, M. T.
    Dobrolecki, L. E.
    Jain, D.
    Sahoo, S.
    Osborne, C. K.
    Chang, J. C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (01) : 189 - 196
  • [4] DNA methylation signature to identify trastuzumab response in HER2 breast cancer models
    Palomeras, S.
    Diaz Lagares, A.
    Blancafort, A.
    Sarrats, A.
    Crujeiras Martinez, A. B.
    Sandoval, J.
    Rabionet, M.
    Welm, A. L.
    Esteller, M.
    Puig, T.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [5] Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer
    Gao, Yinqi
    Wang, Xuelong
    Li, Shihui
    Zhang, Zhiqiang
    Li, Xuefei
    Lin, Fangcai
    [J]. MEDICAL SCIENCE MONITOR, 2021, 27
  • [6] A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis
    Mendaza, Saioa
    Guerrero-Setas, David
    Monreal-Santesteban, Inaki
    Ulazia-Garmendia, Ane
    Cordoba Iturriagagoitia, Alicia
    De la Cruz, Susana
    Martin-Sanchez, Esperanza
    [J]. BIOMEDICINES, 2021, 9 (10)
  • [7] Treatment of Metastatic Breast Cancer - Breast Cancer as a Chronic Disease: Triple Negative Breast Cancer.
    Stearns, V.
    [J]. CANCER RESEARCH, 2011, 71
  • [8] Targeting DNA methylation for treating triple-negative breast cancer
    Yu, Jia
    Zayas, Jacqueline
    Qin, Bo
    Wang, Liewei
    [J]. PHARMACOGENOMICS, 2019, 20 (16) : 1151 - 1157
  • [9] Dual inhibition of chromatin remodeling and DNA methylation as a novel treatment for triple negative breast cancer
    Landry, Joseph W.
    Kang, Jubin
    Morecock, Christiane
    Bear, Harry
    Martin, Rebecca
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [10] DNA methylation predicts response of triple-negative breast cancer to all-trans retinoic acid treatment.
    Coyle, Krysta M.
    Dean, Cheryl A.
    Vidovic, Dejan
    Weaver, Ian
    Giacomantonio, Carman
    Helyer, Lucy
    Marcato, Paola
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 29 - 29
12345